Update on C-reactive protein as a risk marker in cardiovascular disease
1Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany. wolfgang.koenig@medizin.uni-ulm.de
Insights
Systemic inflammation markers, such as C-reactive protein (CRP), are strongly linked to cardiovascular events. Elevated CRP levels indicate increased risk and complications in various patient groups, highlighting its importance in atherosclerosis research.
Area of Science:
- Cardiovascular Research
- Inflammation and Immunology
Background:
- Atherosclerosis involves local inflammation and systemic responses.
- Systemic inflammation markers, like C-reactive protein (CRP), are associated with cardiovascular events.
Purpose of the Study:
- To examine the role of systemic inflammation markers in atherosclerosis.
- To evaluate the clinical significance of C-reactive protein (CRP) in cardiovascular disease.
Main Methods:
- Prospective studies analyzing systemic inflammation markers.
- Clinical data on patients with atherosclerosis and cardiovascular events.
- Experimental research on CRP's role in atherothrombosis.
Main Results:
- Elevated CRP concentrations correlate with cardiovascular events in healthy subjects and patients.
- Increased CRP is linked to complications after interventions and in renal disease.
- CRP testing is increasingly important for primary prevention and emerging indications like glucose disorders.
Conclusions:
- C-reactive protein (CRP) is a significant risk marker for cardiovascular events.
- CRP may play a direct role in the pathogenesis of atherothrombosis.
- Further research on the "inflammation hypothesis" is crucial for atherosclerosis management.
Abstract:
Atherosclerosis is characterized by a nonspecific local inflammatory process, which is accompanied by a systemic response. A number of prospective studies have convincingly demonstrated a strong and independent association between even slightly elevated concentrations of systemic markers of inflammation, like C-reactive protein (CRP), and cardiovascular events in initially healthy subjects and in patients with manifest atherosclerosis. Increased concentrations of CRP were also associated with recurrent instability after discharge, and with early and late complications after percutaneous interventions, bypass operation, and in patients with end-stage renal disease. Recent data have strengthened the role for CRP testing in primary prevention, and potentially new indications like glucose disorders have emerged. In addition, new experimental data suggest that CRP may not only be a risk marker, but may be directly involved in the pathogenesis of atherothrombosis. Testing the "inflammation hypothesis" now represents an important goal for clinical research of atherosclerosis.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
01:30Coronary Artery Disease I: Introduction
01:27Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...